Search

Your search keyword '"Muppidi S"' showing total 149 results

Search Constraints

Start Over You searched for: Author "Muppidi S" Remove constraint Author: "Muppidi S"
149 results on '"Muppidi S"'

Search Results

3. Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

7. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

8. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

9. Low Density Supersonic Decelerator (LDSD) Supersonic Flight Dynamics Test (SFDT) Plume Induced Environment Modelling

11. Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

12. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

13. Eculizumab Improves Fatigue in Refractory Generalized Myasthenia Gravis

15. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

16. Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America

21. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

22. Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)

23. Flow and On-Water Synthesis and Cancer Cell Cytotoxicity of Caffeic Acid Phenethyl Amide (CAPA) Derivatives

24. P.057 Achievement of minimal symptom expression in acetylcholine receptor antibody-positive participants treated with efgartigimod in ADAPT/ADAPT+

26. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

27. Randomized Trial of Thymectomy in Myasthenia Gravis

28. A Genome-wide Association Study of Myasthenia Gravis

29. P.034 Minimal symptom expression following treatment with efgartigimod in patients with Generalized Myasthenia Gravis

37. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

38. US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization.

39. United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use.

40. Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets.

41. Ravulizumab use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.

42. Utilization of APE2 and RITE2 scores in autoimmune encephalitis patients with seizures.

43. Soil Moisture and Heat Level Prediction for Plant Health Monitoring Using Deep Learning with Gannet Namib Beetle Optimization in IoT.

44. Plasma Exchange in Patients With Myositis due to Immune Checkpoint Inhibitor Therapy.

45. Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.

46. Utility of Repetitive Nerve Stimulation in the Diagnosis of Myasthenia Gravis in the Inpatient Setting.

47. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.

48. Neonatal Fc receptor blockade as emerging therapy in diseases with plasma exchange indications.

49. NGLY1 deficiency: a prospective natural history study.

50. Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG).

Catalog

Books, media, physical & digital resources